genetics

First Opinion Sonia M. Suter and Laura Hercher

Dobbs decision is a huge setback for genetic counseling and the people who need it

First Opinion Pamela Feliciano

Genetic research provides new clarity about the ‘whys’ of autism

Health Emiliano Rodríguez Mega

A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end ‘parachute science,’ too?

A STAT Investigation Allison DeAngelis, Adam Feuerstein and Jason Mast

At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say

Biotech Matthew Herper and Megan Molteni

Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

First Opinion Eric B. Kmiec

Secrecy: A demon of gene therapy’s past bedevils its future

Biotech Jason Mast

Beyond a CRISPR treatment’s encouraging results, some scientists see a need for more data on risk

Health Isabella Cueto

Girl’s case of lupus leads to new understanding of a perplexing disease

Pharmalot Ed Silverman

Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results

Health Andrew Joseph

If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn

The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Biotech’s Catch-22, a $100 genome, & dealing with monkeypox

In the Lab Megan Molteni

Buffalo shooting ignites a debate over the role of genetics researchers in white supremacist ideology

First Opinion Anna C. F. Lewis

Substituting genetic ancestry for race in research? Not so fast

First Opinion Walter G. Johnson and Diana M. Bowman

It’s time for Congress to stop blocking mitochondrial replacement therapy

Health Andrew Joseph

Omicron splinters into fast-spreading lineages, highlighting coronavirus’s evolution

Health Megan Molteni

For patients, seeing the benefits of the new, fully sequenced genome could take years

Exclusive Megan Molteni

New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal

Biotech Jonathan Wosen

Illumina sues Guardant Health, saying former employees stole trade secrets to launch liquid biopsy firm

Biotech Jonathan Wosen

Armed with heaps of cash and a veteran team, an upstart looks to disrupt DNA sequencing

Health Lauran Neergaard and Carla K. Johnson — Associated Press

First person to receive a pig heart transplant dies after two months

First Opinion Lee D. Cooper

Rediscovering a language of healing that doesn’t require ‘cure’

Biotech Megan Molteni

With new trial data coming, Intellia CEO talks up the future of in vivo gene editing

In the Lab Eric Boodman

This family carried a rare mutation that should have been lethal. What was keeping them alive?

In the Lab Megan Molteni

Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0

Matt's Take Matthew Herper

The fall of Eric Lander and the end of science’s ‘big ego’ era